Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  KOREA EXCHANGE (KOSDAQ)  >  Seegene Inc    A096530   KR7096530001

SEEGENE INC

(A096530)
  Report
SummaryNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Its low valuation, with P/E ratio at 8.93 and 8.7 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart
Sector Bio Diagnostics & Testing
1st jan.Capitalisation (M$)Investor Rating
SEEGENE INC3 994
EXACT SCIENCES CORPORATION3.29%21 763
GUARDANT HEALTH, INC.14.36%14 735
BGI GENOMICS CO., LTD.31.71%9 694
INVITAE CORPORATION14.06%9 091
ADAPTIVE BIOTECHNOLOGIES CO..-7.59%7 473
IOVANCE BIOTHERAPEUTICS, IN..-8.23%6 246
-
CAREDX, INC3.00%3 819
VERACYTE, INC.5.76%2 997
Q-LINEA AB (PUBL)-11.18%488
BIOVICA INTERNATIONAL AB (P..-14.65%140
EPIGENOMICS AG-24.12%18
More Results
Financials
Sales 2020 1 039 B 0,93 B 0,93 B
Net income 2020 500 B 0,45 B 0,45 B
Net cash 2020 410 B 0,37 B 0,37 B
P/E ratio 2020 8,87x
Yield 2020 0,06%
Capitalization 4 393 B 3 966 M 3 936 M
EV / Sales 2020 3,83x
EV / Sales 2021 3,23x
Nbr of Employees 216
Free-Float 67,3%
Upcoming event on SEEGENE INC
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision